| Item 7.01. | Regulation FD Disclosure |
On November 12, 2021, Sally Beauty Holdings, Inc. (the “Company”) announced that its wholly-owned subsidiaries, Sally Holdings LLC (“Holdings”) and Sally Capital Inc. (together with Holdings, the “Issuers”), issued a conditional notice of redemption, to redeem on December 13, 2021, subject to the satisfaction or waiver of the condition precedent described below, the entire $679.961 million aggregate principal amount of their 5.625% Senior Notes due 2025 (“Notes”) which remain outstanding. The redemption is being made pursuant to the terms of the Indenture dated May 18, 2012, as supplemented by the Third Supplemental Indenture dated December 3, 2015, at a redemption price equal to 101.875% of the principal amount of the Notes plus accrued but unpaid interest, to, but not including, the redemption date.
This redemption is contingent upon the completion by the Issuers of one or more debt refinancing transactions, all upon terms and conditions satisfactory to the Issuers in their sole discretion, in an amount sufficient to make the redemption payment in full. In the Issuers’ discretion, the redemption date may be delayed until such time as such condition precedent shall be satisfied, or such redemption may not occur and the notice of conditional redemption may be rescinded, in the event such condition precedent shall not have been satisfied by the redemption date, or by the redemption date as so delayed.
This report does not constitute a notice of redemption under the Indenture, nor an offer to tender for, or purchase, any Notes or any other security. We cannot provide any assurances about the timing, terms or interest rate associated with the proposed redemption and refinancing, or that the proposed redemption and refinancing transactions can be completed at all.
All of the information furnished in Item 7.01 of this report shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, unless expressly incorporated by reference therein.
Cautionary Notice Regarding Forward-Looking Statements
Statements in this report which are not purely historical facts or which depend upon future events may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, can be identified by the use of forward-looking terminology such as “believes,” “projects,” “expects,” “can,” “may,” “estimates,” “should,” “plans,” “targets,” “intends,” “could,” “will,” “would,” “anticipates,” “potential,” “confident,” “optimistic,” or the negative thereof, or other variations thereon, or comparable terminology, or by discussions of strategy, objectives, estimates, guidance, expectations and future plans. Forward-looking statements can also be identified by the fact that these statements do not relate strictly to historical or current matters.
Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made. Any forward-looking statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including, but not limited to, the risks and uncertainties related to COVID-19 and those described in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended September 30, 2020. Consequently, all forward-looking statements in this release are qualified by the factors, risks and uncertainties contained therein. We assume no obligation to publicly update or revise any forward-looking statements.
